Angiogenesis in Cancers

Tumor progression is linked to a switch in the balance between positive and negative regulators, and mainly depends on the release by inflammatory or neoplastic cells of specific growth factors. Inflammatory infiltration contributes to tumor progression and metastatic process, and there are many rep...

Descripció completa

Guardat en:

Dades bibliogràfiques
Format:	Online
Idioma:	anglès
Publicat:	MDPI - Multidisciplinary Digital Publishing Institute 2023
Matèries:	RBP4 metastasis breast cancer angiogenesis endothelial dysfunction STAT3 VEGF endothelin-1 resveratrol gemcitabine endoglin ERKs microvessel growth lung cancer cancer anticancer DLBCL tumor microenvironment cell adhesion mediated drug resistance tumor progression VEGFR anti-angiogenesis anti-angiogenic agents immunosuppression immunotherapy immune-checkpoint inhibitors combination therapy tumor angiogenesis endothelium microenvironment multiple myeloma adhesion molecules immune-checkpoint inhibitor tumor-derived exosomes small extracellular vesicles feline mammary carcinoma VEGF-A VEGFR-1 VEGFR-2 non-invasive biomarkers selectins E-selectin uproleselan adrenal fetal cortex adrenocortical tumors adrenocortical carcinoma anti-angiogenic drugs bFGF anti-angiogenic therapy resistance vascular permeability drug delivery system microbeam radiation therapy (MRT) Chicken Chorioallantoic Membrane (CAM) U-87 Glioblastoma ginsenoside Rg3 response surface methodology optimisation epimer long pentraxin 3 FGF/FGFR system thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
Accés en línia:	ONIX_20230405_9783036569161_238
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Sigues el primer a deixar un comentari!

Angiogenesis in Cancers

Ítems similars